A clinical study to see the effect of Viola Odorata(homoeopathic medicine) in treatment of Chronic Bronchitis

A single blind clinical study to assess the efficacy of Viola Odorata in management of Chronic Bronchitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049490

Enrollment

Registered

2023-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J42- Unspecified chronic bronchitis

Interventions

Intervention1: Viola Odorata: Potentised homoeopathic medicine Viola Odorata in the form of pills or powder. Dose: Viola Odorata based on the symptom similarity will be prescribed in appropriate pote

Eligibility

Inclusion criteria

Inclusion criteria: 1. Those cases fulfilling the CBSS criteria and suffering is since 2 years or more. 2. Patients of All sexes will be included in the study. 3. Patients of 18 to 40 years age groups of various socio-economic groups will be included. 4. Patient without any other systemic diseases. 5. Patient giving written consent form. 6. Patients coming under the case definition according to CBSS will be included.

Exclusion criteria

Exclusion criteria: 1. That doesn’t fulfill CBSS criteria. 2. Cases with serious complication of Respiratory system and/or recently taking strong steroidal medication and having acute exacerbation of bronchitis. 3. Patients with Psychiatric diagnosis. 4. Pregnant and lactating women. 5. Malignancy cases. 6. Recent major surgery. 7. Immuno compromised cases. 8. Patients who have participated in any other Research study in last 6 months 9.Those under other medications for other diseases.

Design outcomes

Primary

Measure	Time frame
To check the effectiveness of Viola Odorata in cases of Chronic Bronchiti using chronic bronchitis severity scale at day 1 and at every follow up.Timepoint: Improvement according to chronic bronchitis severity scale at day 1 and again after every 15 days, for the total of 12 weeks will be assessed in every case to see the effect of viola odorata.	—

Secondary

Measure	Time frame
To give the maximum relief of symptoms of the patient by following up at every 7 days and to minimize the frequency of symptom of cough and wheezing in patient using CAT assessment.Timepoint: CAT assessment used at day 1 and at every 7 days so assess the frequency of symptoms of cough and wheezing patients within 12 weeks of duration.	—

Countries

India

Contacts

Public ContactDr Ruchita Jerath

BVDU Homoeopathic Medical College, Department of Post Graduate and Research Centre

Neha.jadhavrao@Bharatividyapeeth.edu9923003441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026